Enlivex Therapeutics Ltd. (ENLV)
NASDAQ: ENLV · IEX Real-Time Price · USD
1.380
+0.030 (2.22%)
Jul 22, 2024, 11:29 AM EDT - Market open
Enlivex Therapeutics Employees
Enlivex Therapeutics had 71 employees as of December 31, 2021. The number of employees increased by 21 or 42.00% compared to the previous year.
Employees
71
Change (1Y)
21
Growth (1Y)
42.00%
Revenue / Employee
n/a
Profits / Employee
-$366,056
Market Cap
28.80M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2021 | 71 | 21 | 42.00% |
Dec 31, 2020 | 50 | 14 | 38.89% |
Dec 31, 2019 | 36 | 5 | 16.13% |
Dec 31, 2018 | 31 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Bolt Biotherapeutics | 100 |
Surrozen | 42 |
Palatin Technologies | 34 |
Acasti Pharma | 32 |
Brainstorm Cell Therapeutics | 29 |
bioAffinity Technologies | 14 |
Akari Therapeutics, | 12 |
RenovoRx | 8 |
ENLV News
- 3 days ago - Enlivex Therapeutics and Biotricity Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Accesswire
- 5 weeks ago - Enlivex Announces Positive Interim Data Readout from a Phase I/II Trial Evaluating Allocetra in End-Stage Knee Osteoarthritis - GlobeNewsWire
- 7 weeks ago - Enlivex Therapeutics Closes up to $15 Million Registered Direct Offering - GlobeNewsWire
- 7 weeks ago - Enlivex Therapeutics Announces up to $15 Million Registered Direct Offering - GlobeNewsWire
- 3 months ago - Enlivex Announces Authorization from the Danish Regulatory Agency for the Company's Randomized, Controlled Phase I/II Trial Evaluating Allocetra in Patients with Knee Osteoarthritis - GlobeNewsWire
- 3 months ago - Enlivex to Host Webcast on April 12, 2024 at 8:30 a.m. Eastern Time to Discuss Topline Results from Its Phase II Trial Evaluating Allocetra™ In Patients with Sepsis - GlobeNewsWire
- 3 months ago - Enlivex Announces Topline Results of Its Phase II Trial Evaluating Allocetra™ In Patients With Sepsis - GlobeNewsWire
- 4 months ago - Enlivex Therapeutics and Unusual Machines Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Accesswire